Enter inventor name

Kevin P Campbell

This inventor holds 32 USPTO granted patents and 2 published patent applications, primarily in Muscular Dystrophy Research. Top assignees: University of Iowa Research Foundation, Miles Inc., Regents of the University of Minnesota. Active years: 1988-2018.

USPTO Granted Patents = 32 (Patent Applications = 2)

% Patents Active = 93.8

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 230(Granted Patents)

Location History:

Royal Oak, MI (US) (2007)
Iowa City, IA (US) (1988 - 2018)

Company Filing History:

25 out of 925

University of Iowa Research Foundation

Regents of the University of Minnesota

patents

4. 1 out of 48

Sibia Neurosciences, Inc.

patents

5. 1 out of 751

The Rockefeller University

patents

6. 1 out of 25

The Salk Institute Biotechnology Industrial Associates, Inc.

patents

7. 1 out of 1,379

Washington University

patents

8. 3 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2018

Loading Chart...

Areas of Expertise:

Phosphodiesterase Inhibitors

Muscle Degeneration

Gene Replacement Therapy

Dystrophin Proteins

Calcium Channels

Sarcoglycan Antibodies

Adenocarcinoma

Functional Glycosylation

Mycobacterium Leprae

Malignant Hyperthermia

Dihydropyridine Assay

Immunogenic Derivatives

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9943518 - Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, edema, and damage in a patient having muscle fatigue due to increased age or exercise (2018-04-17),

2. 9387210 - Inhibitors of phosphodiesterase type 5A for treating or preventing muscle disease or the symptoms thereof in a patient (2016-07-12),

3. 8119766 - Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration (2012-02-21),

4. 7287637 - Conveyor system for minimizing product damage during collection (2007-10-30),

5. 6379893 - Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan antibodies (2002-04-30),

6. 6365337 - Genes encoding neuronal voltage-gated calcium channel gamma subunits (2002-04-02),

7. 6331405 - Receptor for Mycobacterium leprae and methods of use thereof (2001-12-18),

8. 6262035 - Gene replacement therapy for muscular dystrophy (2001-07-17),

9. 6211340 - &dgr;-sarcoglycan antibodies (2001-04-03),

10. 6207878 - Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations (2001-03-27),

11. 6201168 - Pathogenesis of cardiomyopathy (2001-03-13),

12. 6136546 - Method for aiding in the diagnosis of in-frame deletion type congenital (2000-10-24),

13. 6083911 - Arenavirus receptor and methods of use (2000-07-04),

14. 5863743 - Merosin deficiency-type congenital muscular dystrophy (1999-01-26),

15. 5837537 - .delta.-sarcoglycan nucleic acid sequences (1998-11-17),

Title: Kevin P Campbell - Innovator from Iowa City

Introduction: Kevin P Campbell is a renowned inventor based in Iowa City, IA, known for his groundbreaking contributions to various fields.

Latest Patents: Kevin P Campbell holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his career, Kevin P Campbell has demonstrated a keen interest in developing cutting-edge solutions that have the potential to revolutionize industries. His work has been recognized for its creativity and practicality.

Collaborations: Kevin P Campbell has collaborated with leading experts in the field, fostering a culture of innovation and knowledge-sharing. His partnerships have led to the development of impactful inventions with real-world applications.

Conclusion: Kevin P Campbell's passion for innovation and his dedication to pushing the boundaries of what is possible make him a standout figure in the world of inventors. His work continues to inspire and drive progress in various sectors.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]